Chang‐Xin Shi

688 total citations
30 papers, 468 citations indexed

About

Chang‐Xin Shi is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Chang‐Xin Shi has authored 30 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Hematology and 5 papers in Immunology. Recurrent topics in Chang‐Xin Shi's work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (10 papers) and Acute Myeloid Leukemia Research (4 papers). Chang‐Xin Shi is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (10 papers) and Acute Myeloid Leukemia Research (4 papers). Chang‐Xin Shi collaborates with scholars based in United States, Canada and China. Chang‐Xin Shi's co-authors include A. Keith Stewart, Xiu-Bao Chang, Marta Chesi, P. Leif Bergsagel, Hongtao Fu, Xueyu Geng, Ziyang Gao, Rodger E. Tiedemann, Yuanqiang Cai and Jun Wang and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Chang‐Xin Shi

30 papers receiving 464 citations

Peers

Countries citing papers authored by Chang‐Xin Shi

Since Specialization

Citations

This map shows the geographic impact of Chang‐Xin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Xin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Xin Shi more than expected).

Fields of papers citing papers by Chang‐Xin Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Xin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Xin Shi. The network helps show where Chang‐Xin Shi may publish in the future.

Co-authorship network of co-authors of Chang‐Xin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Xin Shi. A scholar is included among the top collaborators of Chang‐Xin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Xin Shi. Chang‐Xin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden 2025 ·Blood ·Erin W. Meermeier, (unknown), Joshua Epstein, Meaghen E. Sharik, (unknown), (unknown), Chang‐Xin Shi, Yuan Xiao Zhu, P. Leif Bergsagel, Marta Chesi	2
2	Celmod-Dexamethasone Combination Overcomes Primary Resistance to T Cell Engagers Caused By High Tumor Burden in a Human CRBN+ Preclinical Model of Multiple Myeloma 2024 ·Blood ·Erin W. Meermeier, Meaghen E. Sharik, (unknown), Joshua Epstein, Yuan Xiao Zhu, Chang‐Xin Shi, (unknown), Leif Bergsagel, (unknown)	1
3	Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease 2023 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), (unknown), Morsaleh Ganji, Takumi Toya, Chang‐Xin Shi, Xianfeng Chen, Esteban Braggio, Ali Ahmad, Michel Corban, Keith Stewart, Jenna Fernandez, Zhuoer Xie, Christy M. Finke, Lilach O. Lerman, Mrinal M. Patnaik, Amir Lerman	18
4	Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy 2021 ·Blood Cancer Discovery ·Erin W. Meermeier, Seth J. Welsh, Meaghen E. Sharik, (unknown), Victoria M. Garbitt, Daniel L. Riggs, Chang‐Xin Shi, Caleb K. Stein, (unknown), Bryant Chau, Matthew L. Wheeler, Natalie Bezman, (unknown), Pavel Strop, P. Leif Bergsagel, Marta Chesi	67
5	Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy 2021 ·American Journal of Hematology ·Kitsada Wudhikarn, Leslie Padrnos, Terra L. Lasho, Betsy LaPlant, Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, S. Vincent Rajkumar, Morie A. Gertz, Abhishek A. Mangaonkar, Wilson I. Gonsalves, Rhett P. Ketterling, Chang‐Xin Shi, Rafaël Fonseca, A. Keith Stewart, Mrinal M. Patnaik	13
6	Characterization of the novel protein KIAA0564 (Von Willebrand Domain-containing Protein 8) 2017 ·Biochemical and Biophysical Research Communications ·Moulun Luo, April Mengos, (unknown), Jean Finlayson, (unknown), Yuan Xiao Zhu, Chang‐Xin Shi, (unknown), Wayne T. Willis, Lawrence J. Mandarino	16
7	Crispr Sgrnas Genome-Wide Screen Identifies the Proteasome Regulatory Subunit PSMC6 As a Bortezomib Resistance Gene in Human Multiple Myeloma Cells 2015 ·Blood ·Chang‐Xin Shi, K. Martin Kortüm, Yuan Xiao Zhu, Patrick Jedlowski, Esteban Braggio, Laura A. Bruins, (unknown), Moulun Luo, Robert A. Stewart, Jonathan M. Ahmann, A. Keith Stewart	3
8	Sublingual administration of a helper-dependent adenoviral vector expressing the codon-optimized soluble fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in mice 2014 ·Antiviral Research ·Yuan-Hui Fu, (unknown), Jinsheng He, (unknown), Wei Zhang, Yifei Yan, Yao Ma, Ying Hua, Ying Zhang, Xiang-Lei Peng, Chang‐Xin Shi, Tao Hong	10
9	Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma 2013 ·Acta Biochimica et Biophysica Sinica ·Xiu-Bao Chang, (unknown), Chang‐Xin Shi, A. Keith Stewart	46
10	Cereblon Expression Predicts Response, Progression Free and Overall Survival After Pomalidomide and Dexamethasone Therapy in Multiple Myeloma 2012 ·Blood ·Steven R. Schuster, K. Martin Kortuem, Yuan Xiao Zhu, Esteban Braggio, Chang‐Xin Shi, Laura A. Bruins, Jessica Schmidt, Gregory Ahmann, Shaji Kumar, S. Vincent Rajkumar, Joseph Mıkhael, Vivek Roy, Betsy LaPlant, Kristina Laumann, Bart Barlogie, John D. Shaughnessy, Rafaël Fonseca, Leif Bergsagel, Martha Q. Lacy, Keith Stewart	12
11	Cereblon Binding IMiD Small Molecules Mediate Myeloma Cell Death Via IRF4 2012 ·Blood ·Yuan Xiao Zhu, Chang‐Xin Shi, Laura A. Bruins, K. Martin Kortuem, Jessica Schmidt, Xiu-Bao Chang, Esteban Braggio, Leif Bergsagel, Keith Stewart	1
12	Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB/c mice 2009 ·Biochemical and Biophysical Research Communications ·Yuan-Hui Fu, Jinsheng He, (unknown), Xiaobo Wang, Can Xie, Chang‐Xin Shi, Mei Zhang, Qian Tang, Wei Wei, Jianguo Qu, Tao Hong	10
13	Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1 2009 ·The FASEB Journal ·Dingyan Wang, A. Keith Stewart, Lihua Zhuang, (unknown), Youdong Wang, Chang‐Xin Shi, Armand Keating, Arthur S. Slutsky, Haibo Zhang, Xiao‐Yan Wen	22
14	Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity 2008 ·Journal of Clinical Investigation ·Rodger E. Tiedemann, Xinliang Mao, Chang‐Xin Shi, Yuan Xiao Zhu, Stephen Palmer, Michaël Sébag, (unknown), Marta Chesi, Rafaël Fonseca, P. Leif Bergsagel, Aaron D. Schimmer, A. Keith Stewart	54
15	Restoration of Vitamin C Synthesis in Transgenic Gulo ^−/− Mice by Helper-Dependent Adenovirus-Based Expression of Gulonolactone Oxidase 2008 ·Human Gene Therapy ·Yi Li, Chang‐Xin Shi, Karen Mossman, Jack Rosenfeld, Yong Chool Boo, Herb E. Schellhorn	5
16	The Blimp-1 gene regulatory region directs EGFP expression in multiple hematopoietic lineages and testis in mice 2007 ·Transgenic Research ·Dingyan Wang, Lihua Zhuang, Bo Gao, Chang‐Xin Shi, Joseph Cheung, Mingyao Liu, Tianru Jin, Xiao‐Yan Wen	8
17	A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin 2007 ·Blood ·Xinliang Mao, A. Keith Stewart, Rose Hurren, Alessandro Datti, Xuegong Zhu, (unknown), Chang‐Xin Shi, Kyle Lee, Rodger E. Tiedemann, Yanina Eberhard, Suzanne Trudel, Sheng‐Ben Liang, Seth J. Corey, (unknown), Dwayne L. Barber, Jeffery L. Wrana, Shereen Ezzat, Aaron D. Schimmer	51
18	PRL3 Is a Mediator of IL6/STAT3 Signaling and Defines a Population of Multiple Myeloma Patients Distinct from Those That Activate NFkB. 2007 ·Blood ·Michaël Sébag, Keith Stewart, Chang‐Xin Shi, (unknown), Wee Joo Chng, Jonathan J. Keats, Rodger E. Tiedemann, Rafaël Fonseca, Marta Chesi, P. Leif Bergsagel	1
19	A convenient plasmid system for construction of helper‐dependent adenoviral vectors and its application for analysis of the breast‐cancer‐specific mammaglobin promoter 2006 ·The Journal of Gene Medicine ·Chang‐Xin Shi, Frank L. Graham, Mary Hitt	19
20	[Sequencing of adenovirus type 7 vaccine strain fragment and characterization of the hexon encoding gene]. 2003 ·PubMed ·Xiuli Jiang, Jianwei Wang, Le-ying Wen, Chang‐Xin Shi, Tao Hong	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact